Biosimilars Market Research Reports & Industry Analysis
The worldwide prescription generic drug market has stood the test of time and has endured numerous growing pains. However, it has evolved into a formidable and important participant in the complex world of health care. Generic drugs continue to represent one of the greatest values in healthcare and are of great importance in the area of biopharmaceuticals as well because these products are among the most expensive treatments currently on the market.
Generic drug manufacturers are poised for strong growth in the future because the patent protection for a host of major biopharmaceuticals will expire and new legislative reforms in the generic drug approval process may facilitate bringing products to market. While there are many issues to address, the outlook for the promotion of biosimilars is favorable in the next five years.
Biosimilars Industry Research & Market Reports
-
Global Generic Drugs Market; By Product Type (Simple Generics, Super Generics, and Biosimilars); By Route of Administration (Oral, Topical, Injectable, and Others); By Application (Cardiovascular Products, Anti-infective Drugs, Central Nervous System Drugs, Anti-cancer Drugs, Respiratory Products, and Others); By Distribution Channel (Hospitals/Clinics, Retail Pharmacies, and Online Pharmacies); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Products, and Others); By Distribution Channel (Hospitals/Clinics, Retail Pharmacies, and Online Pharmacies); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028 Generic Drugs Market ... Read More
-
India Generic Drugs Market; By Product Type (Simple Generics, Super Generics, and Biosimilars); By Route of Administration (Oral, Topical, Injectable, and Others); By Application (Cardiovascular Products, Anti-infective Drugs, Central Nervous System Drugs, Anti-cancer Drugs, Respiratory Products, and Others); By Distribution Channel (Hospitals/Clinics, Retail Pharmacies, and Online Pharmacies); Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Products, and Others); By Distribution Channel (Hospitals/Clinics, Retail Pharmacies, and Online Pharmacies); Trend Analysis, Competitive Market Share & Forecast, 2018-2028 India Generic Drugs Market to Grow at 11% during 2022 – 2028 India generic drugs ... Read More
-
Ranibizumab biosimilars - Insight, 2022
... and nonclinical stage products. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It ... Read More
-
Pegfilgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change Including: 1) By Application: Chemotherapy Induced Neutropenia; Transplantation; Others 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Mail-Order Pharmacies Covering: Coherus BioSciences; Biocon/Mylan; Sandoz (Novartis); Intas Biopharmaceuticals Ltd.; Mundipharma GmbH
... pegfilgrastim biosimilars market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how the ... Read More
-
Global Healthcare Digital Experience Platform Market By Component (Platform (without services), and Services), By Application (Business-to-Consumer (B2C), Business-to-Business (B2B), and Others), By Delivery Mode (Cloud and On-premise), By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027
... 2021 - 2027 The Global Healthcare Digital Experience Platform Market size is expected to reach $2.1 billion by 2027, rising at a market growth of 12.8% CAGR during the forecast period. The term Digital Experience ... Read More
-
Europe Healthcare Digital Experience Platform Market By Component (Platform (without services), and Services), By Application (Business-to-Consumer (B2C), Business-to-Business (B2B), and Others), By Delivery Mode (Cloud and On-premise), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027
... - 2027 The Europe Healthcare Digital Experience Platform Market would witness market growth of 12.0% CAGR during the forecast period (2021-2027). For instance, cloud enablement can make life lot simpler for a hospital. A hospital ... Read More
-
Global Biologics CDMO Market (2022 Edition) - Analysis By Type (Mammalian, Non-Mammalian), Product Type (Biologics, Biosimilars), By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2021-2026)
... research report, the global Biologics CDMO Market was valued at USD 9.9 Billion in the year 2020. Growth opportunities for the Biologics CDMO market is attributed to the growth of the geriatric population, rising technical ... Read More
-
North America Healthcare Digital Experience Platform Market By Component (Platform (without services), and Services), By Application (Business-to-Consumer (B2C), Business-to-Business (B2B), and Others), By Delivery Mode (Cloud and On-premise), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027
... 2021 - 2027 The North America Healthcare Digital Experience Platform Market would witness market growth of 11.2% CAGR during the forecast period (2021-2027). Users can interact with a digital experience platform in a variety of ... Read More
-
Global Biopharmaceutical CMO And CRO Market Size study, by Source (Mammalian, Non-mammalian), By Service (Contract Manufacturing, Contract Research), By Product (Biologics, Biosimilars) and Regional Forecasts 2021-2027
... approximately USD 27.6 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6.6 % over the forecast period 2021-2027. Biopharmaceutical CMO And CRO are contract manufacturing organizations and ... Read More
-
Erythropoietin Stimulating Agents Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... revenue of USD 13,436 million in 2026, with a CAGR of 8.6% over the forecast period. According to a research study published in the American Journal of Kidney Disease, 2020, among the patients with COVID-19, ... Read More
-
2022 Global Forecast for Cardiac Safety Services (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Healthcare Analytical Testing Services Market: Current Analysis and Forecast (2022-2028)
... bulk drug materials, intermediates, finished pharmaceutical products, drug formulations, contaminants and degradation products, as well as biological samples containing the medications and their metabolites, is crucial in the field of pharmaceutical research. Thus, a rise ... Read More
-
Next-Generation Antibody Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Therapeutic Area (Oncology and Autoimmune or Inflammatory) and Technology (Antibody-Drug Conjugates, Bispecific Antibodies, Fc Engineered Antibodies, Antibody Fragments and Antibody-Like Proteins, and Biosimilar Antibody Products
... Biosimilar Antibody Products The global next-generation antibody market is expected to reach US$ 12,050.13 million by 2028 from US$ 5,428.41 million in 2021; it is estimated to grow at a CAGR of 11.9% from 2021 ... Read More
-
Etanercept– Biosimilar Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Etanercept Understanding ... Read More
-
Teriparatide– Biosimilar Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Teriparatide Understanding ... Read More
-
Follitropin alfa– Biosimilar Insight, 2022
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage ... Read More
-
Ranibizumab-Biosimilars Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Ranibizumab Understanding ... Read More
-
Epoetin alfa– Biosimilar Insight, 2022
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage ... Read More
-
Filgrastim - Biosimilar Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Filgrastim Understanding ... Read More
-
Somatotropin - Biosimilar Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Somatropin Understanding ... Read More
-
Adalimumab-Biosimilars Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Adalimumab Understanding ... Read More
-
Rituximab-Biosimilars Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Rituximab Understanding ... Read More
-
Insulin Glargine- - Biosimilar Insight, 2022
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage ... Read More
-
Biopharmaceuticals Market by Product (Monoclonal Antibody, Interferon, Insulin, Growth and Coagulation Factor, Erythropoietin, Vaccine, Hormone, And Others) and by Application (Oncology, Blood Disorder, Metabolic Disease, Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology, And Others)- Global Opportunity Analysis and Industry Forecast 2022-2030
... Opportunity Analysis and Industry Forecast 2022-2030 The Biopharmaceuticals Market was valued at USD 345.84 billion in 2021 and is predicted to reach USD 974.48 billion by 2030 with a CAGR of 11.7% from 2022-2030. Biopharmaceutical ... Read More
-
Bevacizumab-Biosimilars Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Bevacizumab Understanding ... Read More
Research Assistance
